Braveheart Bio BRVE
Valuation
Multiples measured against the stock's own five-year history
Near the bottom of its 5-year range · 4th percentile, 5-year average -10.5x
Near the top of its 5-year range · 96th percentile, 5-year average -19.2x
#3978 of 5330 stocks by PB (1 = cheapest)
P/E over five years
Dashed line is the 5-year average; the shaded band is one standard deviation either side.
Morningstar fair value estimate
| Multiple | Current | Forward | 5y average | Percentile vs. own history | Industry rank |
|---|---|---|---|---|---|
| PB | 3.54 | – | -19.23 | 96% (pricier than usual) | #3978 of 5330 (1 = cheapest) |
| PE | -26.77 | -16.74 | -10.52 | 4% (cheaper than usual) | – |
| PS | – | – | 0.00 | – | – |
Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.
No comments yet — be the first to weigh in on BRVE.
Sign in to join the discussion.